Results 251 to 260 of about 25,082 (343)

Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

European Journal of Heart Failure, EarlyView.
Prevalence and predictors of, and outcome associated with history of cancer in patients with heart failure. AF, atrial fibrillation; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CV, cardiovascular; DM, diabetes mellitus; EF, ejection fraction; GDMT, guideline‐directed medical therapy; GI, gastrointestinal; Hb, haemoglobin; HF ...
Pietro Ameri, Paolo Costa, Lina Benson, Davide Stolfo, Nabil V. Sayour, Charlotta Ljungman, Javed Butler, Stefan D. Anker, Nicolas Girerd, Kalliopi Keramida, Gerasimos Filippatos, Lars H. Lund, Felix Lindberg, Gianluigi Savarese   +13 more
wiley   +1 more source

Comparative Effectiveness of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors Versus Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) in Heart Failure With Reduced Ejection Fraction: A Systematic Review. [PDF]

Cureus
Singh P, Sunkara A, Muskan F, Lohana KV, Khan M, Al-Deir SS, Abbas T.   +6 more
europepmc   +1 more source

Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose The increasing number of cancer survivors has caused growing concern over chemotherapy‐induced cardiotoxicity. This study aimed to investigate a novel human model of cardiotoxicity and explore cardioprotection. Experimental Approach Living myocardial slices (LMS) were obtained from explanted end‐stage heart failure ...
Jort S. A. van der Geest, Ilse R. Kelters, Bauke Arends, Willem B. van Ham, Ernest Diez Benavente, Thirza A. Lapré, Petra van der Kraak, Pim van der Harst, Arco J. Teske, Andreas Dendorfer, M. Mostafa Mokhles, Pieter A. Doevendans, Teun P. de Boer, Linda W. van Laake, Joost P. G. Sluijter, Vasco Sampaio‐Pinto   +15 more
wiley   +1 more source

Risk factors of urinary tract infections with sodium-glucose cotransporter-2 inhibitors in heart failure. [PDF]

Medicine (Baltimore)
Zhang YY, Xia BT, Xie AN, Gao ZH, Lou JZ, Liu SJ.   +5 more
europepmc   +1 more source

Use of NT‐proBNP for the screening, diagnosis and risk‐stratification of left ventricular dysfunction

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Heart failure (HF) is a major health problem, and preventing the onset of heart failure could have large cost implications for healthcare systems globally. Screening for heart failure and its precursor, left ventricular dysfunction, could allow patients to receive therapies shown to reduce the risk of incident heart failure, such as ACE ...
Pardeep S. Jhund
wiley   +1 more source

Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma

, 2016
Nuray Erin, Tümay İpekçi, Bahar Akkaya, İrem Hicran Özbudak, Mehmet Baykara   +4 more
openalex   +2 more sources

Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis

The FEBS Journal, EarlyView.
Enhancing endocannabinoid signaling by targeting FAAH effectively mitigates cognitive deficits, reduces amyloid pathology, and modulates neuroinflammatory responses in a preclinical model of Alzheimer's disease. This effect is potentially mediated by attenuating the Aβ‐induced overexpression of the Bace1 gene through CB1‐dependent hypermethylation of ...
Sergio Oddi, Lucia Scipioni, Antonio Totaro, Giacomo Giacovazzo, Francesca Ciaramellano, Daniel Tortolani, Alessandro Leuti, Rita Businaro, Federica Armeli, Andras Bilkei‐Gorzo, Roberto Coccurello, Andreas Zimmer, Mauro Maccarrone   +12 more
wiley   +1 more source

Efficacy of angiotensin receptor neprilysin inhibitor in hypertension management: A systematic review and meta-analysis of clinical trials. [PDF]

Narra J
Ramadhan RN, Rampengan DD, Puling IM, Willyanto SE, Tjandra KC, Thaha M, Multazam CE, Suryantoro SD.   +7 more
europepmc   +1 more source

Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction

, 2016
Marvin A. Konstam
openalex   +1 more source

Implantable Defibrillators: Which Is the Best Device for Each Patient?

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT The first viable alternative to surgical implantation of an epicardial defibrillator system for secondary prevention of sudden cardiac death (SCD) was a single chamber transvenous implantable cardioverter defibrillator (ICD). Thanks to technological advancements over the past 40 years, electrophysiologists now have several options when ...
Graham Peigh, Bradley P. Knight
wiley   +1 more source